Vasomotor symptoms related to perimenopause and menopause in sedentary women are not alleviated by exercise, according to the results of a randomized controlled trial from the MsFLASH Research Network.
The use of conjugated equine estrogens in postmenopausal women aged 50 to 55 years was not associated with any long-term benefit or risk to cognitive function, according to findings of the Women’s Health Initiative Memory Study of Younger Women.
In an unexpected move, the FDA approved Brisdelle (paroxetine), the first non-hormonal treatment for hot flashes associated with menopause, in spite of a recent panel’s recommendation against the drug.
After treating vaginal atrophy with local estrogens, sexual satisfaction for postmenopausal women and their male partners improves, according to the results of a survey published online in the journal Menopause.
Fewer than 20% of obstetrics and gynecology residents receive formal training in menopause medicine. With an expected 50 million menopausal women in the US by 2020, how will we address the knowledge gap?